AI-powered prediction model for neoadjuvant chemotherapy efficacy: comprehensive analysis of breast cancer histological images
Abstract Breast cancer patients exhibit variable responses to neoadjuvant therapy (NAT), necessitating robust predictive biomarkers. We developed an artificial intelligence (AI)-driven integrated predictive model (IPM) combining histopathological, clinical, and immune features to address this challe...
Saved in:
| Main Authors: | Fengling Li, Yani Wei, Wenchuan Zhang, Yuanyuan Zhao, Jing Fu, Xiuli Xiao, Yan Qiu, Yuhao Yi, Yongquan Yang, Hong Bu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-01033-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spatial-temporal radiogenomics in predicting neoadjuvant chemotherapy efficacy for breast cancer: a comprehensive review
by: Tingfeng Zhang, et al.
Published: (2025-06-01) -
Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01) -
Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2007-03-01) -
Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01) -
Research progress of artificial intelligence in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer
by: Wei Wei, et al.
Published: (2024-09-01)